Anand Rajasekharan, PhD, CEO & Co-founder. Anand holds a PhD in Materials Science from Chalmers University of Technology and is one of the inventors of the material platform serving Amferia’s healthcare technology.
Saba Atefyekta, PhD, Sales & Marketing Director & Co-founder. Co- inventor behind Amferia’s technology. Holds a PhD in Materials Science from Chalmers University and her thesis describes the antimicrobial platform of Amferia’s technology. Today, she leads business development in human and animal health.
Martin Andersson, PhD, R&D Director & Co-founder. Fifteen years’ experience in biomedical research with 100 scientific publications. He has previously started a med-tech company for bone implants with successful implementation of products into the market. Professor, Materials Science at Chalmers University.
Ingvar Karlsson, CFO. Previously CFO from both public and private companies covering life science and medtech, automotive and premium consumer goods spanning over 40 years.
Daniel Hagberg, PhD, CTO. Ten years experience in product development and manufacturing from the speciality chemicals and healthcare industry. PhD in Materials Science from Royal Institute of Technology, Sweden
Rojan Modaresi, DVM, PhD, Product Manager, Animal Health. Responsible for Amferia’s wound products for animal care and works at the interface between product development and customer interaction at veterinary clinics across Europe. Doctor of Veterinary Medicine and PhD in Microbiology from Urmia University, Iran.
Edvin Blomstrand, PhD., Research Engineer. Responsible for the product design and device optimization for wound care applications. Skilled in material design, antimicrobial testing and cell-material assessment. PhD in Materials Science from Chalmers University.
Maya Awada, MSc., Research Engineer. Responsible for the new product design and development for wound care applications. Skilled in material chemistry and antimicrobial testing. MSc in Biotechnology from Chalmers University.
Peter Andersson, Director of Commercial Partnerships. Leads business development and sales, responsible for new partnerships for Amferia with Strategics and Distributors across the globe. Peter has 20+ years expereince from sales and BD in medtech, pharma and diagnostics.
Therese Rydell, Director of Quality and Regulatory Affairs. Leads quality and regulatory affairs at Amferia. Therese has 10+ years expereince from QA/RA leadership roles in medtech and diagnostics.
My Sjöblom, Research Engineer. Responsible for the product design and device optimization for wound care applications. Skilled in material design, antimicrobial testing, microfluidics and cell-material assessment. Holds PhD in Biotechnology from Chalmers University.
Ulrika Holmquist, Clinical Development Manager. Responsible for the clinical development of Amferia wound care for animal health. Ulrika is authrorised veterinarian in Sweden and a professional race horse jockey.
Dorotea Soja, Quality and Regulatory Operations Co-ordinator. Responsible for the supporting documentation, compliance processes, and continuous improvement activities. Previous expereince as technical communications specialist from several med-tech companies
Board of Directors
Agneta Edberg, Chair. Previously Nordic Senior VP of Mylan, COO Bactiguard, Marketing Director at Pharmacia, Pfizer and CEO NM Pharma and several life science board assignments
Martin Andersson, PhD, Co-founder. Professor in Materials Science at Chalmers University and co-inventor of Amferia Technology. Co-founder of Promimic AB, an bone-implant scale-up.
Anders Husmark. Industry expert in wound care and surgical devices. Previously R&D Director of Surgical at Mölnlycke Health care and Business Development Director at RLS Global
Henrik Jansson, Investment Director & CEO at Almi Invest VästSvergie, previously CEO of several SMEs
Randy Schwartz. 40 years of global healthcare leadership experience, including driving the commercialization of industry-leading wound care technologies during his tenure at Mölnlycke Health Care. Currently serving as a principal at Med Market Consultants and a Board Member of the Wound Care Collaborative Community.
Nikolaj Sorensen. Experienced life science executive who brings extensive expertise in pharmaceutical commercialization andinternational corporate leadership. Currently serving as the President and CEO of Orexo AB, his career also includes senior management positions at Pfizer Inc., including Managing Director of Pfizer AB, and strategic advisory roles as a management consultant with the Boston Consulting Group.
Advisors
Dr. Christian Nees, Clinical Advisor Animal Health, Veterinary surgeon with 35 years of experience in surgery and wound care. Previously the head of Animal Health Hospital in Weingarten (Kleintierzentrum Weingarten), Germany.
